On Wednesday 17 June, the European Commission formally adopted its strategy for vaccination, which proposes that Member States jointly enter into advance purchase agreements with pharmaceutical companies developing a vaccine against Covid-19 (see EUROPE B12503A2).
The communication, which received the informal support of EU Health Ministers last week (see EUROPE B12505A1), is accompanied by a proposal for a Regulation to temporarily derogate from the rules on genetically modified...